Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis
Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis
Active, not recruiting · NCT07396467 · Registry updated 2026-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis | Fibrosis, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, disease, interstitial lung disease, lung disorder, lung neoplasm, neoplasm, pulmonary fibrosis, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2026-03-17 | NCT07396467 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital with Nanjing Medical University | 319 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Nanjing Medical University | Nanjing | China | 43 |